Based upon a patient's PreVu test results, formal risk assessment under their healthcare provider's direction, including blood cholesterol testing and global risk assessment, may be warranted, or should be considered. The PreVu POC Test does not diagnose the presence or absence of coronary artery disease (CAD), but without blood draw or fasting it can quickly identify individuals who may possess hidden, higher levels of risk of CAD by measuring their skin cholesterol levels, and encouraging them to see their doctors. Clinical studies have shown that elevated skin cholesterol is strongly associated with an increased risk of serious atherosclerotic disease. PreVu is not a substitute for blood serum cholesterol testing.
About The PreVu® Non-Invasive Skin Cholesterol Test
The PreVu® Point of Care (POC) Test is a non-invasive, risk assessment technology designed to measure Skin Cholesterol - an important new biomarker in assessing risk of coronary artery disease (CAD). The PreVu® POC Test is completely painless, non-invasive, involves no blood draw or needles, and requires no overnight fasting. This in vitro diagnostic test is conducted on the palm of the hand in less than 5 minutes with results being immediately available, facilitating point of care consultation and a next steps discussion. Skin Cholesterol is the cholesterol that has been deposited and diffused into tissue, as opposed to freely circulating in the bloodstream, and the skin contains approximately 11% of all the cholesterol found in the human body. Elevated Skin Cholesterol has been shown in clinical studies to be strongly associated with significant CAD as measured by treadmill stress testing and coronary angiography, as well as measured by testing for coronary calcium, carotid artery thickening, and carotid artery plaque. The PreVu® Point of Care Test does not diagnose the presence or absence of CAD, but helps to identify patients who may be at higher, hidden risk for CAD by measuring this new biomarker. For more information visit www.prevu.com.
About Miraculins Inc.
Miraculins is a medical diagnostic company focused on acquiring, developing and commercializing non-invasive tests for unmet clinical needs. A significant number of promising diagnostic opportunities remain un-commercialized because of the sizable gap between the discovery stage, when research institutions are typically involved, and the commercialization stage, when the larger commercial enterprises become interested. Miraculins has direct experience in bridging this gap. The Company's PreVu® technology is a revolutionary new coronary artery disease risk assessment technology that measures cholesterol levels in a patient's skin non-invasively, painlessly and without the need for fasting. Miraculins is also advancing a suite of biomarkers to aid in the early detection of the devastating disease of pregnancy known as preeclampsia. The Company's preeclampsia program is partnered with Alere Inc. (formerly known as Inverness Medical Innovations), one of the world's largest diagnostic companies. For more information visit www.miraculins.com.
Based in Dartmouth, Nova Scotia, PharmaChoice is a member-owned cooperative that represents independent pharmacy owners across Canada. Launched in 1999, PharmaChoice empowers independent drug stores to combine professional services with a wide range of competitively priced products adapted to customer needs. The PharmaChoice philosophy is embodied in the slogan "Advice for Life" and the organization lives that promise everyday as an integral part of healthcare in the communities it serves. There are over 350 locations that rely on the strength of the PharmaChoice brand to leverage their buying power and supply them with various marketing programs. PharmaChoice delivers the following services to its membership: Buying Power; Marketing Tools; Technology Solutions; Value Added Programs; and Best Practices. As such the pharmacists' role is seen as that of recognized community leader, whose commitment to their patients make them an important member of their patient's health care team. In addition to counseling and responding to people's health and wellness queries, the pharmacist is also a patient's best friend. Head Office backs PharmaChoice members with a robust support system that provides an array of innovative ways for pharmacists to remain committed to their patients. For more information visit www.pharmachoice.com.
Most Popular Stories
- AIG to Create 230 Jobs in Charlotte
- Bipartisan Negotiators Reach Modest Budget Agreement
- Justin Bieber Visits Typhoon Victims, Plays Concert
- Senate Dems Move Forward With Obama Nominees
- Russia Says Nyet to Canada North Pole Claim
- New Obama Aide to Focus on Climate Change
- Obama Nominee Confirmed for D.C. Appeals Court
- MasterCard to Split Shares, Raise Dividend
- GOP, Dems Strain to Unearth a Modest Budget Pact
- Office Depot Moving HQ to Florida